The Biggest Breakthrough in Regenerative Medicine

Can Regenerative Medicine Actually Slow Down Arthritis? A Chicago Rheumatologist Explains

If you’ve been living with knee pain, you’ve probably heard about platelet-rich plasma (PRP) or stem cell injections as options for arthritis treatment in Chicago. Most people assume these treatments only do one thing: relieve pain.

But recent research is revealing something much bigger — and it could change the way patients think about protecting their joints for the long term.

Dr. Siddharth Tambar, a Chicago rheumatologist and regenerative medicine specialist at Chicago Arthritis, has been treating patients with orthobiologics — including PRP and bone marrow concentrate — since 2008. Here’s what he wants patients to understand about the newest breakthrough in regenerative medicine in Chicago.

Why “Realistic Expectations” Matter in Regenerative Medicine

In lab studies, scientists can create a small cartilage injury in an animal, apply cells, and watch it heal almost completely. It sounds impressive — but it isn’t how real patients present in a clinic.

Most people seeking joint pain relief have a much more complicated history. A typical patient might be:

• In their 60s, dealing with knee pain today
• Someone who had a sports injury decades earlier
• A patient with multiple past injuries or surgeries, like an arthroscopy
• Someone who has already tried steroid injections
• A person whose joint has simply aged and worn down over 40+ years

This is why regenerative medicine isn’t a “one and done” miracle cure — but it is a powerful tool when used correctly.

What Regenerative Medicine Has Traditionally Offered

For years, PRP therapy and bone marrow concentrate injections have provided real, measurable benefits for patients with osteoarthritis and joint injuries, including:

• Improved ligament stability and joint function
• Reduced pain in the treated joint
• Better quality of life for up to five years after treatment

These outcomes alone have made regenerative medicine a valuable option for patients looking to avoid or delay surgery. But newer research points to something even more significant.

The Breakthrough: Disease Modification, Not Just Pain Relief

Here’s the key difference patients need to understand:

• Pain relief helps you feel better.
• Disease modification actually changes how the condition progresses over time.

Until recently, regenerative medicine could offer the first — but not consistently the second. That’s changing.

What the Research Shows

New data suggests that injecting bone marrow concentrate directly into the subchondral bone (the bone just beneath the cartilage), rather than only into the joint space, may meaningfully change the trajectory of osteoarthritis.

One notable study, led by French orthopedic surgeon Dr. Philippe Hernigou, looked at patients with osteoarthritis in both knees. Each patient received two different treatments:

• One knee was treated with an injection into the joint only
• The other knee was treated with an injection into the bone itself

The Results

• Both knees experienced pain relief
• But the knee treated with a bone injection showed a significantly lower rate of progression toward needing knee replacement surgery

In other words, treating the bone — not just the joint — appears to slow the disease process itself.

Why This Matters for Patients with Osteoarthritis

For patients with moderate to advanced osteoarthritis, the expected path has traditionally looked like this: pain gradually worsens, function declines, and eventually knee replacement surgery becomes necessary.

This new approach suggests that, when caught at the right stage and treated with the right technique, that path isn’t necessarily fixed. Using a patient’s own bone marrow concentrate — injected into the bone rather than just the joint — may help:

• Slow the progression of arthritis
• Delay or potentially reduce the need for joint replacement surgery
• Provide longer-lasting relief compared to joint-only injections

Is This Right for You?

Every patient’s situation is different. Factors like the stage of osteoarthritis, joint history, and overall health all play a role in determining whether regenerative medicine — and specifically bone-targeted treatment — is an appropriate option.

If you’re dealing with:

• Chronic knee or joint pain
• Osteoarthritis that hasn’t responded well to conservative treatment
• Autoimmune or inflammatory joint conditions
• A desire to explore alternatives to surgery

…it may be worth having a conversation with a rheumatology specialist who has direct experience with these techniques.

The Bottom Line

Regenerative medicine has already helped many patients manage joint pain and improve function. But the ability to actually influence the progression of osteoarthritis — not just mask its symptoms — represents a meaningful shift in arthritis care.

As Dr. Tambar puts it, this may be the biggest breakthrough in regenerative medicine since he began practicing in 2008.

Learn More About Regenerative Medicine in Chicago

If you’re looking for personalized guidance on osteoarthritis treatment, PRP therapy, or autoimmune disease treatment, the team at Chicago Arthritis is here to help.

👉 Visit ChicagoArthritis.com to learn more about our regenerative medicine programs or to schedule a consultation with a Chicago rheumatologist.